Effects of psilocybin on time perception and temporal control of behaviour in humans

@article{Wittmann2007EffectsOP,
  title={Effects of psilocybin on time perception and temporal control of behaviour in humans},
  author={Marc Wittmann and Olivia L. Carter and Felix Hasler and B. Rael Cahn and Ulrike Grimberg and Philipp Spring and Daniel Hell and Hans Flohr and Franz X. Vollenweider},
  journal={Journal of Psychopharmacology},
  year={2007},
  volume={21},
  pages={50 - 64}
}
Hallucinogenic psilocybin is known to alter the subjective experience of time. However, there is no study that systematically investigated objective measures of time perception under psilocybin. Therefore, we studied dose-dependent effects of the serotonin (5-HT)2A/1A receptor agonist psilocybin (4-phosphoryloxy-N, N-dimethyltryptamine) on temporal processing, employing tasks of temporal reproduction, sensorimotor synchronization and tapping tempo. To control for cognitive and subjective… 
Effects of varied doses of psilocybin on time interval reproduction in human subjects
TLDR
In both experiments, kappa was significantly increased by psilocybin at 90 min from the drug intake, indicating a higher loss rate of the internal duration representation, tentatively linked to qualitative alterations of subjective time in altered states of consciousness.
Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
TLDR
It is suggested that the disrupting effects of psilocybin on automatic and controlled inhibition processes are attributable to 5-HT2AR stimulation, and ketanserin alone had no significant effects.
Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors
TLDR
It is speculated that this impaired attentional performance may reflect a reduced ability to suppress or ignore distracting stimuli rather than reduced attentional capacity.
The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial
TLDR
These results suggest that microdose LSD produces temporal dilation of suprasecond intervals in the absence of subjective alterations of consciousness, and this effect is most pronounced in the 10 μg dose condition.
Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans
TLDR
It is proposed that altered states of consciousness induced by pharmacological treatments and neurological disorders can reveal much about the circuitry underlying time perception in normal states of Consciousness.
Tolerability, assessment, and prediction of psilocybin-induced altered states of consciousness
TLDR
Three empirical studies were conducted based on pooled data from Prof. Vollenweider’s research group at the University Hospital of Psychiatry in Zurich, finding that the effects of psilocybin were generally well tolerated and most subjects described the experience as pleasurable, enriching, and non-threatening.
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
TLDR
The results suggest that the administration of moderate doses of psilocybin to healthy, high-functioning and well-prepared subjects in the context of a carefully monitored research environment is associated with an acceptable level of risk.
Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice
TLDR
It is confirmed that psilocin acts as an agonist at 5-HT1A, 4-hydroxy-N,N-dimethyltryptamine, and 5- HT2C receptors in mice, whereas the behavioral effects of 1-methylpsilocin indicate that this compound is acting at5-HT2A sites but is inactive at the 5-ht1A receptor.
Setting the beat of an internal clock: Effects of dexamphetamine on different interval ranges of temporal processing in healthy volunteers
TLDR
Findings in healthy humans indicate that the dexamphetamine-induced increase in the speed of the internal pacemaker was modulated by the basal working memory capacity of each participant, which has important implications for the role of dopamine, and its contributions to timing deficits, in models of psychiatric disorders.
Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users
TLDR
Acute ayahuasca administration impaired working memory but decreased stimulus–response interference, and detrimental effects on higher cognition were only observed in the less experienced group, rather than leading to increased impairment.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 86 REFERENCES
Effects of the Hallucinogen Psilocybin on Covert Orienting of Visual Attention in Humans
TLDR
Results are in line with both bilateral impairment of disengagement of attention and a lateralized impairment of inhibition of return (IOR) in productive psychotic states and the suggested relationship between visuospatial attentional dysfunction and acute psychotic conditions.
Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors
TLDR
It is speculated that this impaired attentional performance may reflect a reduced ability to suppress or ignore distracting stimuli rather than reduced attentional capacity.
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study
TLDR
PY affects core dimensions of altered states of consciousness and physiological parameters in a dose-dependent manner and provided no cause for concern that PY is hazardous with respect to somatic health.
Neuropharmacological Evidence for Different Timing Mechanisms in Humans
  • T. Rammsayer
  • Psychology, Medicine
    The Quarterly journal of experimental psychology. B, Comparative and physiological psychology
  • 1999
TLDR
The overall pattern of results supports the notion that temporal processing of longer intervals is mediated by working-memory functions and, therefore, any pharmacological treatment, irrespective of the neurotransmitter system involved, that produces a deterioration of working memory, may interfere with temporal processed intervals.
Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia
TLDR
Evidence that deficient MMN generation in schizophrenia may be a relatively distinct manifestation of deficient NMDAR functioning is indirectly supported by effects of the 5-HT2A receptor agonist psilocybin on the same measures in 18 healthy volunteers.
Brain mechanisms of hallucinogens and entactogens
TLDR
Recent brain imaging and behavioral studies of sensory gating functions suggest that disruption of cortico-subcortical processing leading to sensory overload of the cortex is a communality of these psychoses.
Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations with the Mixed 5-HT2A and 5-HT1A Agonist Psilocybin
TLDR
The involvement of serotonergic pathways in binocular rivalry is suggested and supports the previously proposed role of a brainstem oscillator in perceptual rivalry alternations and symptoms of psychosis.
5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride
TLDR
The present results indirectly support the hypothesis of a serotonin-dopamine dysbalance in schizophrenia and suggest that psilocybin is a valuable tool in the analysis of serotonin- dopamine interactions in acute psychotic states.
Dopaminergic and serotoninergic influence on duration discrimination and vigilance.
TLDR
Both dopaminergic and serotoninergic changes in DD seemed to be independent of the level of vigilance, and performance in DD was slightly improved by the 5-HT agonist and the5-HT antagonist.
A systems model of altered consciousness: integrating natural and drug-induced psychoses
TLDR
Cross-species studies of homologues gating functions in animal and human models of psychosis corroborate this view and provide a translational testing mechanism for the exploration of novel pathophysiologic and therapeutic hypotheses relevant to psychotic disorders, such as the group of schizophrenias.
...
1
2
3
4
5
...